Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04865640 · ClinicalTrials.gov registry record

Clinical Validation Study for Noninvasive Cardiopulmonary Management Device

A clinical trial of Cardiopulmonary Disease, sponsored by Analog Device.

Completed
Registry status
40
Enrollment target
1
Study location

NCT04865640 is a study of Cardiopulmonary Disease that has completed, run by Analog Device. The registered enrollment target is 40 participants, below the 524-participant average among 4 other Cardiopulmonary Disease trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04865640, a study of Cardiopulmonary Disease, has completed, sponsored by Analog Device.

COMPLETED
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

The ADI At-Home CPM (Cardiopulmonary Management) System is a non-invasive device that measures and trends a variety of biological parameters. This study will be conducted as a prospective non-randomized study with two study arms/cohorts - one of healthy adult patients, one of pathologic patients who fit into the intended use population of the CPM System.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Noninterventional and noninvasive

Study Locations (1)

Minnesota

  • Mayo Clinic Hospital - Rochester

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-11-19
Est. Completion 2021-02-16

Sponsor

Analog Device

5 total trials

What the Registry Record Tells You About NCT04865640

The ClinicalTrials.gov registry entry for NCT04865640 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 524-participant average among 4 other Cardiopulmonary Disease trials with a reported enrollment target (92% lower). The listed sponsor is Analog Device, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiopulmonary Disease appearing as the primary indexed condition, and to 1 intervention - of which Noninterventional and noninvasive is the first listed.

NCT04865640 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04865640 about?

NCT04865640 is a clinical study titled "Clinical Validation Study for Noninvasive Cardiopulmonary Management Device". The ADI At-Home CPM (Cardiopulmonary Management) System is a non-invasive device that measures and trends a variety of biological parameters. This study will be conducted as a prospective non-randomized study with two study arms/cohorts - one of healthy adult patients, one of pathologic patients wh...

What is the current status of trial NCT04865640?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2020-11-19. Estimated completion is 2021-02-16.

What conditions does trial NCT04865640 study?

This clinical trial studies the following conditions: Cardiopulmonary Disease.

What interventions are being tested in trial NCT04865640?

The interventions under investigation include: Noninterventional and noninvasive (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04865640?

This trial is sponsored by Analog Device, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04865640 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiopulmonary Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.